Table 1. Patient and disease... | American Society of Hematology

Table 1.

Patient and disease characteristics in 4 randomized trials

	Disease	Stage	No. of patients (original report)	No. of patients with long-term follow-up (%)	Median age at transplant, y	Follow-up (original report, in mo)
Blaise et al	AML	First CR	101	100	32	23 ± 11
Clift et al	CML	CP	147	96.5	37	Minimum 12
Devergie et al	CML	CP	120	98.3	36	42
Ringden et al	CML/AML	CP/CR1	46/51	98.4	33	1-50
	CML/AML	Advanced	11/19

	Disease	Stage	No. of patients (original report)	No. of patients with long-term follow-up (%)	Median age at transplant, y	Follow-up (original report, in mo)
Blaise et al	AML	First CR	101	100	32	23 ± 11
Clift et al	CML	CP	147	96.5	37	Minimum 12
Devergie et al	CML	CP	120	98.3	36	42
Ringden et al	CML/AML	CP/CR1	46/51	98.4	33	1-50
	CML/AML	Advanced	11/19

CR indicates complete remission; CP, chronic phase.